Schedule 13D ownership disclosure

Arbutus Biopharma Corp

Security class unavailable · CUSIP: 03879J100

Event date: 2016-07-08

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
16,013,540
Percent of class
29.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-16-132418
Form type
SC 13D
Filer
Arbutus Biopharma Corp
CIK
CIK 1447028
Filed
Jul 13, 2016
Reporting period
Jul 08, 2016
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub

SC 13D | SEC Filings Hub